Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
Press Room
Immunization Action Coalition
Contact: Julie Murphy
(651) 647-9009
Email: julie@immunize.org
 
November 11, 2015
 
Leading Medical and Public Health Organizations Join the Immunization Action Coalition in Urging Health Care Professionals to Improve Second Dose Meningococcal Meningitis Vaccination Rates
Despite CDC recommendations, fewer than 30% of teens have received the second vaccination needed for completing protection against meningococcal meningitis; national call-to-action for health care professionals to improve this statistic.
Read "Dear Colleague" letter
St. Paul November 11, 2015 The American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College Health Association (ACHA), Centers for Disease Control and Prevention (CDC), Immunization Action Coalition (IAC) and Society for Adolescent Health and Medicine (SAHM), have issued a joint call-to-action (www.immunize.org/letter/letter_promoting_meningococcal_vaccination.pdf) urging health care professionals to strongly recommend and administer the second (booster) dose of meningococcal ACWY vaccine (MenACWY or "MCV4") at age 16.
According to CDC, the meningococcal meningitis booster vaccination rate is an estimated 28.5% for eligible teens, an alarming statistic, compared to 79.3% for the primary dose.1 CDC strongly recommends a booster dose at age 16, after an initial vaccination at age 11 or 12, because protection wanes in most teens within five years after the primary vaccination.2 By vaccinating fewer than 1 in 3 eligible teens, we are leaving millions of young adults without the protection they need against potentially deadly and crippling meningococcal disease.3
"A clinician's endorsement of immunization has long been recognized as a key factor in improving immunization rates," said Anne Schuchat, MD, principal deputy director of CDC.
Teens are at an increased risk of meningococcal meningitis due to common everyday activities such as sharing utensils and water bottles, and kissing.4,5,6 Meningococcal meningitis has a 10–15% fatality rate and cases have occurred in which an otherwise healthy young person will contract the illness, become severely sick, and die in as little as 24 hours after the first symptoms appear.
To further help improve meningococcal meningitis immunization rates, IAC has developed several resources that are available on its website at  www.immunize.org/meningococcal.
"IAC believes that we need to help encourage health care professionals to learn about their second dose MCV4 coverage rate and to provide them with helpful tools to increase rates," said Deborah Wexler, MD, executive director of IAC. "Unfortunately, many parents are not aware that they are not fully protecting their teens — they simply do not know that a second (booster) dose of MCV4 is recommended, and they often rely on their provider to track their teen's immunization schedule."
Health care professionals can visit www.Give2MCV4.org to download free educational materials and tools, including fact sheets, talking points, an overview of adolescent immunization recommendations, Q&As, and other useful resources.
About the Immunization Action Coalition
The Immunization Action Coalition (IAC) works to increase immunization rates and prevent disease by creating and distributing educational materials for health professionals and the public that enhance the delivery of safe and effective immunization services. IAC also facilitates communication about the safety, efficacy, and use of vaccines within the broad immunization community of patients, parents, health care organizations, and government health agencies.
 
Read "Dear Colleague" letter
References:
  1. Centers for Disease Control and Prevention. (2015). National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014. Retrieved July 30, 2015, from www.cdc.gov/mmwr/preview/mmwrhtml/mm6429a3.htm.
  2. Centers for Disease Control and Prevention. (2011, January 28). Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR). Retrieved May 6, 2015, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a3.htm.
  3. United States Census Bureau. (2013). Age and Sex Composition in the United States. Retrieved March 24, 2015, from census.gov/population/age/data/2012comp.html.
  4. Stephens, D.S.; Greenwood, B.; Brandtzaeg, P. (2007). Epidemic Meningitis, Meningococcaemia, and Neisseria Meningitis. Lancet. 369 (9580), 2199.
  5. Centers for Disease Control and Prevention. (2012, March 15). Meningococcal Disease. About: Causes and Transmission. Retrieved May 7, 2013, from http://www.cdc.gov/meningococcal/about/causes-transmission.html.
  6. Centers for Disease Control and Prevention. (2014, April 1). Meningococcal Disease Risk Factors. Retrieved March 13, 2015, from http://www.cdc.gov/meningococcal/about/risk-factors.html.
This page was updated on November 11, 2015
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
ACIP RECOMMENDATIONS
ADDITIONAL RESOURCES
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Combination Vaccines
Diphtheria
Hepatitis A
Hepatitis B
Vaccine Storage and Handling
>> view all
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR
CDC INFORMATION
CDC SCHEDULES
CLINIC RESOURCES
Administering Vaccines
Documenting Vaccination
Scheduling Vaccination
Screening for Contraindications
Storage & Handling
Vaccine Recommendations
>> view all
COALITIONS
CONTRIBUTE TO IAC
DEAR COLLEAGUE LETTER
HPV VACCINE
DEAR COLLEAGUE LETTER
MCV4 DOSE #2
DISEASES & VACCINES
Diphtheria
Hepatitis A
Hepatitis B
Influenza
Varicella
>> view all
DONATE TO IAC
EMAIL NEWS SERVICES
EDUCATIONAL MATERIALS
FAQs
FAVORITES (WEB SECTIONS)
FDA PRODUCT APPROVALS
GIVE BIRTH TO THE END OF
HEP B
HANDOUTS FOR PATIENTS &
STAFF
Administering Vaccines
Adult Vaccination
Documenting Vaccinations
Managing Vaccine Reactions
Parent Handouts
Patient Schedules
Questions & Answers
Recommendations
Screening Checklists
Standing Orders
Storage & Handling
Talking with Parents
Temperature Logs
Top Handouts
Translations
Vaccine Index
>> view all
HEPATITIS B BIRTH DOSE
HONOR ROLLS
HepB Birth Dose
Influenza Vaccination for HCP
IAC EXPRESS
IMAGES
IMMUNIZATION TECHNIQUES
DVD
LAMINATED SCHEDULES
MANUFACTURERS
NATIONAL ADULT & INFLUENZA IMMUNIZATION SUMMIT
NEWS & INFORMATION
OFFICIAL RELEASES
ACIP
CDC
FDA
>> view all
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POWERPOINT SLIDE SETS
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
REGISTRIES
RESOURCE DIRECTORY
SHOP IAC
Immunization Techniques DVD
Laminated Schedules
Patient Record Cards
>> view all
SITE MAP
SLIDE SETS
STANDING ORDERS TEMPLATES
STATE INFORMATION
State Websites
State Laws
State Immunization Managers
>> view all
SUBSCRIBE
SUPPORT IAC
TECHNICALLY SPEAKING
TRANSLATE FOR IAC
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE REPORTS
Chickenpox
Diphtheria
Hepatitis A
Hepatitis B
>> view all
VACCINATING ADULTS: A STEP-BY-STEP GUIDE
VACCINE CONCERNS
Adjuvants & Ingredients
Alternative Medicine
Autism
Importance of Vaccination
>> view all
VACCINE INFORMATION STATEMENTS
Translations
Vaccine Index
>> view all
VACCINE MANUFACTURERS
VACCINE POLICY & LICENSURE
ACIP
FDA
WHO
>> view all
VACCINE SAFETY
VACCINES & DISEASES
VIDEOS (VIDEO OF THE WEEK)
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs
Web Sections
>> view all
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.